Cargando…

Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension

Azilsartan–chlorthalidone fixed combination is a new drug in the management of hypertension. Azilsartan has been shown to have greater blood pressure-lowering effects than other angiotensin-receptor blockers (ARBs), and the debate regarding the superiority of chlorthalidone over hydrochlorothiazide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shuster, Jerrica E, Bleske, Barry E, Dorsch, Michael P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383350/ https://www.ncbi.nlm.nih.gov/pubmed/22745562 http://dx.doi.org/10.2147/VHRM.S22583

Ejemplares similares

Azilsartan/chlorthalidone combination therapy for blood pressure control
por: Cheng, Judy WM
Publicado: (2013)

Spectrophotometric and Spectrofluorimetric Studies on Azilsartan Medoxomil and Chlorthalidone to Be Utilized in Their Determination in Pharmaceuticals
por: Ebeid, Walid M, et al.
Publicado: (2014)

A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone
por: Weber, Michael A, et al.
Publicado: (2018)

Effects of Food Intake on the Pharmacokinetics of Azilsartan Medoxomil and Chlorthalidone Alone and in Fixed‐Dose Combination in Healthy Adults
por: Dudkowski, Caroline, et al.
Publicado: (2016)

A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension
por: Cushman, William C., et al.
Publicado: (2018)

Safety, Tolerability, and Efficacy of Azilsartan Medoxomil With or Without Chlorthalidone During and After 8 Months of Treatment for Hypertension
por: Kipnes, Mark S., et al.
Publicado: (2015)

Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis
por: Kumar, Lakshya, et al.
Publicado: (2023)

Efficacy and Safety of Valsartan or Chlorthalidone vs. Combined Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The VACLOR Study
por: Manzur, Fernando, et al.
Publicado: (2018)

Azilsartan: Current Evidence and Perspectives in Management of Hypertension
por: Pradhan, Akshyaya, et al.
Publicado: (2019)

Efficacy and Safety of a Single-Pill Fixed-Dose Combination of Azilsartan and Amlodipine
por: Motozato, Kota, et al.
Publicado: (2016)

Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension
por: Weber, Michael A., et al.
Publicado: (2014)

Efficacy and Safety of Azilsartan and Telmisartan in Hypertensive Patients
por: Kumar, Alok, et al.
Publicado: (2021)

Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients
por: Chekka, Lakshmi Manasa S., et al.
Publicado: (2022)

Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER‐Prevention Randomized Clinical Trial
por: Fuchs, Sandra Costa, et al.
Publicado: (2016)

Chlorthalidone-Induced Fixed-Drug Eruption: Unmasking an Uncommon Reaction to a Common Diuretic
por: Marrero Castillo, Mariana, et al.
Publicado: (2023)

New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil
por: Volpe, Massimo, et al.
Publicado: (2012)

Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy
por: Angeloni, Emiliano
Publicado: (2016)

Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazide
por: Bashir, Khalid, et al.
Publicado: (2022)

Effect of Switching to Azilsartan From Fixed-Dose Combination of an Angiotensin II Receptor Blocker and Calcium Channel Blocker or a Thiazide in Patients With Hypertension
por: Miyoshi, Toru, et al.
Publicado: (2019)

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
por: Hripcsak, George, et al.
Publicado: (2020)

Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients
por: Dineva, Stela, et al.
Publicado: (2020)

Tailoring Chlorthalidone Aqueous Solubility by Cocrystallization: Stability and Dissolution Behavior of a Novel Chlorthalidone-Caffeine Cocrystal
por: Rodríguez-Ruiz, Christian, et al.
Publicado: (2022)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Comparison of the Effectiveness and Safety of Chlorthalidone and Hydrochlorothiazide in Patients With Hypertension: A Meta-Analysis
por: Khenhrani, Raja Ram, et al.
Publicado: (2023)

Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
por: Segura, Julian, et al.
Publicado: (2011)

PSUN274 Chlorthalidone-Induced Diabetic Ketoacidosis.
por: Zafar, Rafia, et al.
Publicado: (2022)

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
por: Mengden, Thomas, et al.
Publicado: (2009)

Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertension
por: Johnson, Wallace, et al.
Publicado: (2017)

Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients
por: Fernandes, Leticia Aparecida Barufi, et al.
Publicado: (2016)

Critical evaluation of the efficacy and tolerability of azilsartan
por: De Caterina, Alberto R, et al.
Publicado: (2012)

Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial
por: Dash, Ashish, et al.
Publicado: (2023)

EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry
por: Gitt, Anselm K, et al.
Publicado: (2013)

Possible combined effect of perindopril and Azilsartan in an experimental model of dementia in rats
por: Alzahrani, Yahya M., et al.
Publicado: (2020)

Drug-induced acute myopia following chlorthalidone treatment
por: Mahesh, G, et al.
Publicado: (2007)

Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide—meta-analysis
por: Dineva, Stela, et al.
Publicado: (2019)

Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination
por: Pimenta, Eduardo, et al.
Publicado: (2008)

Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
por: Juhasz, Attila, et al.
Publicado: (2018)

Efficacy and safety of sacubitril/valsartan after switching from azilsartan in hemodialysis patients with hypertension
por: Iwashima, Yoshio, et al.
Publicado: (2023)

Hyperlipidemia medication management in patients admitted for a myocardial infarction
por: Shuster, Jerrica E., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gglp8t4rvtgngfulkf2n99pc29